Fatal hepatotoxicity associated with AMSA therapy.
作者信息
Appelbaum F R, Shulman H M
出版信息
Cancer Treat Rep. 1982 Oct;66(10):1863-65.
PMID:6957265
Abstract
摘要
相似文献
1
Fatal hepatotoxicity associated with AMSA therapy.与氨茴霉素治疗相关的致命肝毒性。
Cancer Treat Rep. 1982 Oct;66(10):1863-65.
2
Acute electrocardiographic changes induced by amsacrine.安吖啶引起的急性心电图改变
Cancer Treat Rep. 1984 Sep;68(9):1169-72.
3
Trial of AMSA in acute leukemia.急性髓系肉瘤在急性白血病中的试验。 （注：原文中“AMSA”表述可能有误，推测可能是“急性髓系肉瘤”相关词汇，但按正确的医学概念，“急性白血病”里没有“AMSA”这种准确的病理表述，这里是按照字面翻译。如果原文有误，你可以补充准确信息以便更准确翻译。）
Cancer Treat Rep. 1982 Jul;66(7):1596-7.
4
AMSA therapy for children with lymphoblastic malignancy.急性髓系肉瘤（AMSA）疗法用于治疗患有淋巴细胞性恶性肿瘤的儿童。
Cancer Treat Rep. 1982 Mar;66(3):593-4.
5
m-AMSA: phase II trial in advanced lymphoma and leukemia.
Am J Clin Oncol. 1984 Aug;7(4):357-60.
6
7
Amsacrine in refractory acute leukemia.安吖啶治疗难治性急性白血病。
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):787-9.
8
Amsacrine (AMSA)--a clinical review.安吖啶（AMSA）——临床综述。
J Clin Oncol. 1985 Apr;3(4):562-92. doi: 10.1200/JCO.1985.3.4.562.
9
Phase II trial of amsacrine (AMSA) in urinary bladder cancer.
Cancer Treat Rep. 1983 Apr;67(4):391-2.
10
Evaluation of AMSA in children with acute leukemia. A Pediatric Oncology Group study.儿童急性白血病中AMSA的评估。一项儿科肿瘤学组研究。
Cancer. 1984 Jul 15;54(2):207-10. doi: 10.1002/1097-0142(19840715)54:2<207::aid-cncr2820540205>3.0.co;2-0.
引用本文的文献
1
Intestinal and liver toxicity of antineoplastic drugs.抗肿瘤药物的肠道和肝脏毒性
West J Med. 1984 Feb;140(2):250-9.
2
The effect of buthionine sulphoximine, cimetidine and phenobarbitone on the disposition of amsacrine in the rabbit.丁硫氨酸亚砜胺、西咪替丁和苯巴比妥对兔体内安吖啶处置的影响。
Cancer Chemother Pharmacol. 1986;18(3):208-12. doi: 10.1007/BF00273387.
3
Treatment of acute leukaemia with m-AMSA in combination with cytosine arabinoside.
Cancer Chemother Pharmacol. 1986;18(1):59-62. doi: 10.1007/BF00253066.
Zotero 插件